Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Immunotherapy, Adoptive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07435701
What this trial is testing

Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

Who this might be right for
Ovarian Neoplasms MalignantAscites
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Early research (Phase 1)Ended earlyNCT02577588
What this trial is testing

Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Carcinoma
National Center for Tumor Diseases, Heidelberg 1
Testing effectiveness (Phase 2)Looking for participantsNCT07328503
What this trial is testing

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaB-All
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00834665
What this trial is testing

Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 59
Testing effectiveness (Phase 2)Study completedNCT00026897
What this trial is testing

Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer

Who this might be right for
Neoplasm
National Cancer Institute (NCI) 100
Early research (Phase 1)Ended earlyNCT03661424
What this trial is testing

BATs in Patients With Breast Cancer and Leptomeningeal Metastases

Who this might be right for
Breast Cancer FemaleLeptomeningeal Metastases
University of Virginia 3
Testing effectiveness (Phase 2)Study completedNCT00513604
What this trial is testing

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental+1 more
National Cancer Institute (NCI) 158
Early research (Phase 1)Study completedNCT02775292
What this trial is testing

Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1

Who this might be right for
Adult Solid NeoplasmChildhood Solid NeoplasmMetastatic Neoplasm
Jonsson Comprehensive Cancer Center 1
Early research (Phase 1)UnknownNCT03068624
What this trial is testing

Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal Melanoma
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00923910
What this trial is testing

Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

Who this might be right for
Leukemia, Acute Myelogenous (AML)Leukemia, Acute Lymphocytic (ALL)Leukemia, Chronic Myelogenous (CML)+2 more
National Cancer Institute (NCI) 10
Early research (Phase 1)Looking for participantsNCT06926894
What this trial is testing

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Who this might be right for
Epstein-Barr VirusCytomegalovirus InfectionsAdenovirus+2 more
Monica Bhatia 18
Not applicableStudy completedNCT00001353
What this trial is testing

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00001832
What this trial is testing

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
National Cancer Institute (NCI) 170
Testing effectiveness (Phase 2)Ended earlyNCT00924001
What this trial is testing

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Ended earlyNCT01218867
What this trial is testing

CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer

Who this might be right for
Metastatic CancerMetastatic MelanomaRenal Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01993719
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT00110578
What this trial is testing

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Ended earlyNCT01814046
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma

Who this might be right for
Metastatic Ocular MelanomaMetastatic Uveal Melanoma
National Cancer Institute (NCI) 24
Not applicableAvailableNCT05398640
What this trial is testing

Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

Who this might be right for
Unresectable MelanomaMetastatic Melanoma
Iovance Biotherapeutics, Inc.
Testing effectiveness (Phase 2)UnknownNCT03166878
What this trial is testing

A Study Evaluating UCART019 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma

Who this might be right for
B Cell LeukemiaB Cell Lymphoma
Chinese PLA General Hospital 80
Next Page